Walleye Trading’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,000
Closed -$62.3K 4426
2025
Q4
$62.3K Buy
+6,000
New +$63K ﹤0.01% 3895
2024
Q3
Sell
-7,000
Closed -$144K 4366
2024
Q2
$144K Buy
7,000
+4,800
+218% +$98.7K ﹤0.01% 3234
2024
Q1
$46.9K Buy
+2,200
New +$42.8K ﹤0.01% 4038
2022
Q4
Sell
-3,100
Closed -$42K 5191
2022
Q3
$42K Buy
+3,100
New +$47.8K ﹤0.01% 4287
2021
Q1
Sell
-19,900
Closed -$650K 5055
2020
Q4
$650K Buy
+19,900
New +$699K ﹤0.01% 2419

Other funds holding KURA

Walleye Trading's KURA Position: Q1 2026 in Review

Walleye Trading sold out of Kura Oncology (KURA) in Q1 2026, closing a stake of 7,055 shares — an estimated $73.3K sold.

Walleye Trading first reported a position in KURA in Q1 2018 and held it in 7 quarters. The position peaked at $2.25M in Q2 2018. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Walleye Trading reported no remaining Kura Oncology position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 7,055 Kura Oncology shares in Q1 2026, an estimated $73.3K.
  • Walleye Trading first reported a position in Kura Oncology in Q1 2018 and held it in 7 quarters.
  • Walleye Trading's Kura Oncology position peaked at $2.25M in Q2 2018.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.